INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Cytiva's Aseptic Filling Workcell User Group
Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.
-
Isolators For Pharmacy Compounding – Time For Change?
Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.
-
Thermo Fisher Scientific Large Volume Liquid Expansion
Take an insightful look into the expansion of the large volume liquids manufacturing site at the Grand Island facility, highlighting the various stages of the manufacturing process and the capabilities it offers to support the bioprocessing industry.
-
Syntegon Virtual Pharma Expo May 2025: Aseptic Manufacturing And Packaging
The 2022 EU GMP Annex 1 revision marks a pivotal shift in sterile manufacturing, emphasizing contamination control, advanced technologies, and global harmonization—driving industry-wide adaptation and regulatory interpretation challenges.
-
Sterility Testing Of Products With Antimicrobial Properties6/4/2024
Drugs formulated with antibiotics, preservatives, or other chemicals may inhibit microbial viability and growth. Learn more about three golden rules to be effective against antimicrobial effects.
-
Rethinking Liquid Handling Automation10/1/2025
Labs today require more than precision—they need systems built for flexibility, reproducibility, and trust. Explore how automation is evolving to meet the real-world needs of modern scientific teams
-
Advanced Isolator Tech Boosts Manufacturing Efficiency And Quality7/30/2024
Isolator technology can run continuously over several days, minimizing operator interaction and other opportunities to introduce contamination — ideal for high-volume, time-limited production runs.
-
Powering The Next Generation Of Drug Delivery Systems12/4/2025
Discover how pharmaceutical extrusion, including aseptic methods, enables advanced drug delivery systems, detailing the critical process controls required for success with complex and novel drug products.
-
A New Approach To Isolator Decontamination4/8/2024
How can you address the decontamination challenges associated with isolated fill-finish operations? New innovations are being implemented to ensure superior sporicidal reduction and operational safety.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
We are the exclusive manufacturing partner for this innovative auto-injector platform.
-
The aseptic/sterile Fill-Finish equipment solutions need to be cGMP compliant, dependable and accurately designed to comply with the most recent revisions of the “Annex 1 Manufacture of Sterile Medicinal Products guidelines”. Newly designed equipment needs to accommodate for small batches, various speeds and containers, including RTU / RTF (Ready To Use or Ready To Fill) bottles, vials, cartridges, syringes and pre-sterile nested trays. Moreover, the filling equipment solution should also improve the ergonomic use for operators and maximize cleanroom efficiency.
-
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
-
Personal protection pharmaceutical isolators enables personal protection for operators when handling toxic substances.
-
Containment is a major concern for GMP industries. With a proven track record in managing highly technical and challenging isolation projects Dec is the perfect partner for the integration of new or existing equipment by providing comprehensive safe, ergonomic and dedicated containment solutions.